Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 4, 2016
Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping
Guopei Luo, Meng Guo, Kaizhou Jin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 2, 2018
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
Stacy J Kowalsky, Zuqiang Liu, Mathilde Feist, et al.
Current Oncology (Toronto, Ont.)
|
September 26, 2025
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal Carcinomatosis
Christopher Sherry, Neda Dadgar, Zuqiang Liu, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Cancers
|
April 14, 2026
Non-Secreted Mature Decoy-Resistant IL-18-Armed Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in an Aggressive Murine Ovarian Cancer Model
Pingpo Ming, Chunyan Li, Junjie Ye, et al.
International Journal of Molecular Sciences
|
July 12, 2016
The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
Meng Guo, Guopei Luo, Chen Liu, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
Min Yang, Esther Giehl, Chao Feng, et al.
Oncotarget
|
April 16, 2016
Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
Chen Liu, Yu Lu, Guopei Luo, et al.
Oncoimmunology
|
May 6, 2015
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency
Yi Zhang, Shenghe Tian, Zuqiang Liu, et al.
Theranostics
|
June 7, 2021
Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation
Lingjuan Chen, Hongqi Chen, Junjie Ye, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 4, 2016
Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping
Guopei Luo, Meng Guo, Kaizhou Jin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 2, 2018
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
Stacy J Kowalsky, Zuqiang Liu, Mathilde Feist, et al.
Current Oncology (Toronto, Ont.)
|
September 26, 2025
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal Carcinomatosis
Christopher Sherry, Neda Dadgar, Zuqiang Liu, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Cancers
|
April 14, 2026
Non-Secreted Mature Decoy-Resistant IL-18-Armed Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in an Aggressive Murine Ovarian Cancer Model
Pingpo Ming, Chunyan Li, Junjie Ye, et al.
International Journal of Molecular Sciences
|
July 12, 2016
The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
Meng Guo, Guopei Luo, Chen Liu, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
Min Yang, Esther Giehl, Chao Feng, et al.
Oncotarget
|
April 16, 2016
Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
Chen Liu, Yu Lu, Guopei Luo, et al.
Oncoimmunology
|
May 6, 2015
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency
Yi Zhang, Shenghe Tian, Zuqiang Liu, et al.
Theranostics
|
June 7, 2021
Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation
Lingjuan Chen, Hongqi Chen, Junjie Ye, et al.
Page
of 8